Aveva Drug Delivery Systems Inc.

Form 483 issued September 1, 2023 · Miramar, Florida

Inspection
Aug 28 – Sep 1, 2023
Investigator
Steven A. Brettler
Observations
2
Pages
2
FEI number
1000307689

In short: On September 1, 2023, FDA issued a Form 483 with 2 observations to Aveva Drug Delivery Systems Inc. in Miramar, Florida (FEI 1000307689) after an inspection that ran Aug 28 – Sep 1, 2023. The investigator was Steven A. Brettler. Most observations concern packaging & labeling and facilities & equipment; the most-cited regulation is 21 CFR 211.122 (materials examination and usage criteria).

At a glance

Packaging & labeling and facilities & equipment account for 2 of 2 observations.

Packaging & labeling1
Facilities & equipment1

Most cited: 21 CFR 211.122(d) (1×) · 211.52 (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Access to the storage area for labels and labeling materials is not…

  2. 02

    Washing and toilet facilities lack…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Aveva Drug Delivery Systems Inc.?

FDA listed 2 observations on this Form 483, mostly about packaging & labeling and facilities & equipment. The most-cited regulation is 21 CFR 211.122 (materials examination and usage criteria). The opening words of each observation are shown on this page.

Who inspected Aveva Drug Delivery Systems Inc.?

Steven A. Brettler is named on this Form 483, for the inspection of Aug 28 – Sep 1, 2023. Each investigator has a profile showing what they cite most.

When was Aveva Drug Delivery Systems Inc. inspected by FDA?

The inspection ran Aug 28 – Sep 1, 2023, and the Form 483 is dated September 1, 2023.

How do I get the full Form 483 for Aveva Drug Delivery Systems Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free